|
|
|
||||
| Home Help Feedback Subscriptions Archive Search | |||||
The fully linked HTML version of this article has now been published.
TOM1 and its related proteins, TOM1-like1 (TOM1-L1) and TOM1-like2 (TOM1-L2), constitute a subfamily of the VHS domain protein family. We have recently shown that endofin, a FYVE domain protein associated with the early endosome, is able to recruit cytosolic TOM1 onto endosomal membranes. To reveal the biological consequence of endofin-mediated endosomal recruitment of TOM1, we have identified the clathrin heavy chain as a major interacting protein for TOM1. Optimal clathrin binding by TOM1 involves three sites: residues 300-321, 321-326 and a putative clathrin-binding box at residues 362-366 (362LEDEF366). Although residues 321-326 could function independently as a weak clathrin-binding motif, deletion of amino acids 300-321 or mutation of 362Leu and 364Asp to Ala residues reduced the binding of clathrin to TOM1. A fragment lacking amino acids 300-322 and containing 362Leu and 364Asp to Ala mutations lost the ability to interact with clathrin. Remarkably, overexpression of endofin led to a massive and specific recruitment of clathrin [but not dynamin, or the adaptor protein (AP) complexes, AP1, AP2 or AP3] onto endofin-positive endosomes. Although SARA is homologous to endofin, it did not interact with the C-terminal region of TOM1. Examination of chimeric proteins of endofin and SARA suggests that the C-terminal half of endofin is responsible for interaction with the C-terminal region of TOM1 and for recruitment of TOM1 and clathrin to endosomes. The correlation between the ability of endofin to interact with the C-terminal domain of TOM1 and clathrin recruitment suggests that endofin may recruit clathrin via TOM1. Indeed, a chimeric protein consisting of TOM1 fused to two FYVE domains derived from endofin has the ability to recruit clathrin onto endosomal structures. Moreover, we show that affinity-purified TOM1 antibody can abolish binding of clathrin to the C-terminal region of TOM1. Upon microinjection into cells, this antibody reduced the membrane association of clathrin. These results, taken together, suggest that TOM1 is an important molecule for membrane recruitment of clathrin, and that endofin is able to exploit this recruitment at the endosome.
This article has been cited by other articles:
JCS ePress
online publication date 18 Jan 2005
doi: 10.1242/jcs.01628
This Article ![]()
![]()
Full Text (PDF)
![]()
All Versions of this Article:
jcs.01628v1
118/3/575
most recent![]()
Alert me when this article is cited
![]()
Alert me if a correction is posted
![]()
Services ![]()
![]()
Email this article to a friend
![]()
Similar articles in this journal
![]()
Similar articles in PubMed
![]()
Alert me to new issues of the journal
![]()
Download to citation manager
![]()
![]()
Citing Articles ![]()
![]()
Citing Articles via HighWire
![]()
Citing Articles via Google Scholar
![]()
Google Scholar ![]()
![]()
Articles by Seet, L.-F. ![]()
Articles by Hong, W. ![]()
Search for Related Content
![]()
PubMed ![]()
![]()
PubMed Citation
![]()
Articles by Seet, L.-F.
![]()
Articles by Hong, W.
![]()
Social Bookmarking ![]()
![]()
What's this?
Research Article
Endofin recruits clathrin to early endosomes via TOM1
* Author for correspondence (e-mail: mcbhwj{at}imcb.a-star.edu.sg)
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
![]()
![]()

![]()
![]()
![]()
C. Murphy
Endo-fin-ally a SARA for BMP receptors
J. Cell Sci.,
April 1, 2007;
120(7):
1153 - 1155.
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
W. Shi, C. Chang, S. Nie, S. Xie, M. Wan, and X. Cao
Endofin acts as a Smad anchor for receptor activation in BMP signaling
J. Cell Sci.,
April 1, 2007;
120(7):
1216 - 1224.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
Y.-G. Chen, Z. Wang, J. Ma, L. Zhang, and Z. Lu
Endofin, a FYVE Domain Protein, Interacts with Smad4 and Facilitates Transforming Growth Factor-beta Signaling
J. Biol. Chem.,
March 30, 2007;
282(13):
9688 - 9695.
[Abstract]
[Full Text]
[PDF]
![]()
© The Company of Biologists Ltd 2005